MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10620-020-06344-w

Медицинская библиотека · Digestive diseases and sciences · 2020

Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.

Rolston Vineet S, Kimmel Jessica, Popov Violeta, Bosworth Brian P, Hudesman David, Malter Lisa B, Hong Simon, Chang Shannon

СтатьяМетаанализСистематический обзорПеревод пока не подготовлен

Аннотация

GOALS AND

BACKGROUND

Ustekinumab (UST) is a monoclonal antibody inhibitor of IL-12/IL-23 approved for the treatment of Crohn's disease (CD) and ulcerative colitis (UC). We conducted a meta-analysis to compare rates of adverse events (AEs) in randomized controlled trials (RCTs) of UST for all indications.

STUDY: A systematic search was performed of MEDLINE, Embase, and PubMed databases through November 2019. Study inclusion included RCTs comparing UST to placebo or other biologics in patients aged 18 years or older with a diagnosis of an autoimmune condition.

RESULTS

Thirty RCTs with 16,068 patients were included in our analysis. Nine thousand six hundred and twenty-six subjects were included in the UST vs placebo analysis. There was no significant difference in serious or mild/moderate AEs between UST and placebo with an OR of 0.83 (95% CI 0.66, 1.05) and 1.08 (95% CI 0.99, 1.18), respectively, over a median follow-up time of 16 weeks. In a sub-analysis of CD and UC trials, no difference in serious or mild/moderate AEs in UST versus placebo was seen.

CONCLUSIONS

UST was not associated with an increase in short-term risk of AEs.

Для цитирования: Rolston Vineet S, Kimmel Jessica, Popov Violeta, Bosworth Brian P, Hudesman David, Malter Lisa B, Hong Simon, Chang Shannon. Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.. Digestive diseases and sciences. 2020. DOI: 10.1007/s10620-020-06344-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.